Immunogenicity of nonreplicating recombinant vaccinia expressing HLA-A201 targeted or complete MART-1/Melan-A antigen

Cancer Gene Therapy

Volumn 8, Issue 9, 2001, Pages 655-661

  Schütz, Alexander ^a   Oertli, Daniel ^b   Marti, Walter R ^b   Noppen, Christoph ^b   Padovan, Elisabetta ^b   Spagnoli, Giulio C ^b   Heberer, Michael ^b   Zajac, Paul ^b  

^a University Hospital   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Immunogenicity; MART 1 Melan A; Minigene; Vaccinia virus

Indexed keywords

CIPROFLOXACIN; EPITOPE; GAMMA INTERFERON; MELAN A; RECOMBINANT VACCINE; VACCINIA VACCINE; VIRUS VECTOR;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CALCIUM MOBILIZATION; CELL PROLIFERATION; CELL SURVIVAL; CYTOTOXIC T LYMPHOCYTE; ENDOPLASMIC RETICULUM; GENE TARGETING; IMMUNE RESPONSE; IMMUNOGENICITY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR OCCUPANCY; VACCINIA VIRUS; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0034804540     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700351     Document Type: Article

References (27)

1. MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies
2. TAP (transporter associated with antigen processing)-independent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences located at the amino- but not carboxyl-terminus of the peptide
3. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1
4. Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses
5. Phase I trial of a recombinant vaccinia virus encoding carcinoembryonic antigen in metastatic adenocarcinoma: Comparison of intradermal versus subcutaneous administration
6. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL
7. Heterogeneity of biologic responses of melanoma-specific CTL
8. The efficiency of antigen recognition by CD8+ CTL clones is determined by the frequency of serial TCR engagement
9. Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: Implications for tumor vaccines with melanoma-associated antigens
10. Processing and delivery of peptides presented by MHC class I molecules
11. High cytokine production and effective antitumor activity of a recombinant vaccinia virus encoding murine interleukin 12
12. Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells
13. Design and evaluation of antigen-specific vaccination strategies against cancer
14. Therapeutic vaccination for cancer
15. Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues
16. Vaccinia as a vector for tumor-directed gene therapy: Biodistribution of a thymidine kinase-deleted mutant
17. HLA-independent heterogeneity of CD8+ T cell responses to MAGE-3, Melan-A/MART-1, gp100, tyrosinase, MCIR, and TRP-2 in vaccine-treated melanoma patients
18. Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted Melan-A/MART-1 antigenic peptide in melanoma
19. Peptide-specific CTL in tumor infiltrating lymphocytes from metastatic melanomas expressing MART-1/Melan-A, gp100 and Tyrosinase genes: A study in an unselected group of HLA-A2.1-positive patients
20. Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen
21. Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light
22. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy
23. Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue
24. Dendritic cells infected with a vaccinia vector carrying the human gp100 gene simultaneously present multiple specificities and elicit high-affinity T cells reactive to multiple epitopes and restricted by HLA-A2 and -A3
25. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers
26. Generating MHC class I ligands from viral gene products
27. Generation of tumoricidal cytotoxic T lymphocytes from healthy donors after in vitro stimulation with a replication-incompetent vaccinia virus encoding MART-1/Melan-A 27-35 epitope